In:
Blood, American Society of Hematology, Vol. 126, No. 25 ( 2015-12-17), p. 2713-2719
Kurzfassung:
In myeloma patients, trisomy 3 improved time to progression and trisomies 3 and/or 5 improved overall survival. In contrast, trisomy 21 significantly worsened overall survival.
Materialart:
Online-Ressource
ISSN:
0006-4971
,
1528-0020
DOI:
10.1182/blood-2015-06-650242
Sprache:
Englisch
Verlag:
American Society of Hematology
Publikationsdatum:
2015
ZDB Id:
1468538-3
ZDB Id:
80069-7